1. Introduction
===============

Total joint arthroplasty (TJA) is a successful and cost-effective elective surgical intervention that is widely used to treat disabling joint pain mainly caused by osteoarthritis. Periprosthetic joint infection (PJI) as 1 of the main complications following TJA has attracted more solicitous attentions from orthopedic surgeons. Though PJI affects 0.5% to 1.2% of primary total hip arthroplasties, it still remains a major complication that is associated with high morbidity and healthcare expenditure^\[[@R1]\]^\--for example the mortality in elderly patients can reach 8% due to the infection following joint arthroplasties^\[[@R2],[@R3]\]^. There is a pressing need to facilitate the prevention of PJIs and its risk factors.

Obesity as a high risk of osteoarthritis has a prevalence of over 60% in patients undergoing TJA^\[[@R4],[@R5]\]^. Some studies have further graded the severity of obesity, showing that morbid obesity and super obesity are strongly associated with postoperative complications compared with milder forms^\[[@R6],[@R7]\]^.

Lately, though the correlation between body mass index (BMI) and PJI following TJA have been reported by many, they have yielded inconsistent results. This may attribute to the small sample size and univariate analyses unadjusted for confounders in some meta-analyses^\[[@R8]--[@R10]\]^ despite their conclusion of an uncertain correlation. In this study, we retrieved the published studies on PJI after TJA, extracted high-relevant multi-factor data with adjustment for confounders for the subsequent systematic review and meta-analyses, and evaluated the significance of the BMI, aiming at paving the way for the prevention and treatment of this complication.

2. Methods
==========

2.1. Search strategies
----------------------

This study was executed in line with the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses^\[[@R11]\]^ and reported based on the guidelines developed by the Meta-Analysis of Observational Studies in Epidemiology group^\[[@R12]\]^. Because all the analyses were performed on the basis of previous published studies, no ethical approval or informed consent was required. In the initial screening, 2 investigators (J-LX and B-LX) independently conducted the main search in the electronic databases of PubMed, Embase and Cochrane Library to retrieve eligible articles on the correlation between BMI and PJI after TJA from the inception of the databases to September 2019, without restrictions to languages, publication types or regions. The combined terms of medical subject headings and non- medical subject headings were searched as follows: "Arthroplasty, Replacement", "Arthroplasties, Replacement", "Joint Prosthesis Implantation", "Implantation, Joint Prosthesis", "Implantations, Joint Prosthesis", "Joint Prosthesis Implantations", "Prosthesis Implantation, Joint", "Prosthesis Implantations, Joint", "Replacement Arthroplasty", "Joint Replacement", "Joint Replacements", "Replacement, Joint", "Replacements, Joint", "Replacement Arthroplasties", "Total Joint Replacement", "Joint Replacement, Total", "Joint Replacements, Total", "Replacement, Total Joint", "Replacements, Total Joint", "Total Joint Replacements", "Prosthesis-Related Infections", "Prosthesis Related Infections", "Infections, Prosthesis-Related", "Prosthesis-Related Infection", "PJI", "periprosthetic joint infection", "prosthetic joint infections", "periprosthetic infections", "infection of joint", "joint infection", "Body Mass Index", "Index, Body Mass", "Quetelet Index", "Index, Quetelet", "Quetelet\'s Index", "Quetelets Index", "Obesity", "fat" and "Obese". A third investigator irrelevant to the initial procedure was consulted in case of any discrepancy.

2.2. Study selection criteria
-----------------------------

Two independent investigators (J-LX and Z-RL) analyzed the initially selected articles to verify their relevance with the topic of BMI and PJI after TJA. The following items of inclusion criteria should be considered:

1.  participants were selected without limitations to regions, ages or social status;

2.  studies (except for reviews) had sufficient original data to describe the correlation between BMI and PJI after TJA;

3.  studies based on either case-control, cross-sectional, or retrospective or prospective design.

4.  Trials were excluded as with the following identifications: duplicate or overlapping data, animal experiments, conference abstracts, letters and review articles.

In case of any disagreement the results were discussed and unified by senior authors.

2.3. Data extraction
--------------------

Data from the included studies were extracted and independently categorized by 2 authors (X-BL and Q-ZZ) using a predefined data extraction form. All disagreements were resolved by discussions. Design information, baseline population characteristics (mean age, sample size and country), surgical approaches, risk factors from all included studies were stratified into a standardized evidence table. All data were rechecked to ensure accuracy. Study selections were shown in a the Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram (Fig. [1](#F1){ref-type="fig"}).

![The flow diagram of literature search and selection.](medi-99-e20549-g001){#F1}

2.4. Methodological quality assessment
--------------------------------------

The methodological quality of the included studies was evaluated by 2 independent reviewers (J-LX and T-YL) based on the items of modified Newcastle-Ottawa Scale^\[[@R13]\]^, comprising patient selection, study group comparability and outcome assessment. The observational studies scored 0 to 9. Distinct opinions were discussed among the authors.

2.5. Statistical analysis
-------------------------

The meta-analysis and statistical analysis were performed using Stata 13.0 software (Stata Corp). The odds ratio (OR) and 95% confidence interval (CIs) were calculated. The *I*-square (*I*^2^) test was adopted to evaluate the influence of heterogeneity on the output of the meta-analysis. *I*^2^ values of 0%, 25%, 50%, and 75% represented no, low, medium and high heterogeneity, respectively. Heterogeneity was tested using Cochran *Q* statistic and the *I*^2^ metric: a *I*^2^ \> 25% was the cutoff of significant heterogeneity, and a fixed-effect model was used when a *I*^2^ \< 25%; otherwise, a random-effect model was preferred^\[[@R14]\]^. A *P* value of less than .05 was accepted as statistical significant. A sensitivity analysis^\[[@R15]\]^ was conducted by excluding 1 study at a time to evaluate the quality and consistency of the results. Egger and Begg linear regression tests for publication bias were carried out. Subgroup analyses were performed according to different countries, study designs, operation methods and different grades of BMI.

3. Results
==========

3.1. Study selection process
----------------------------

As a result, 505 references were initially retrieved, 403 were left after eliminating duplicate literature; and then 337 without high-relevant to our topic were discarded by reading titles and abstracts, and 66 studies remained. Finally, 37 full-text articles were abandoned because of the following reasons: 7 studies on irrelevant topics; 1 study without sufficient data for extraction; 23 studies without OR values; 3 studies showing non-multivariate adjusted OR values; 3 studies without free online full-text materials. Therefore, 29 observational studies representing 3,204,887 patients were included in the meta-analysis. The flow chart describing the selection process was shown in Fig. [1](#F1){ref-type="fig"}.

3.2. Study characteristics and methodological quality
-----------------------------------------------------

The 29 included references encompassed retrospective cohort, retrospective case-control, prospective cohort, and prospective case-control studies, with the publication years differing from 2008 to 2019. Two were conducted in China (including 1 in Taiwan), 17 in the United States, 2 in New Zealand, Finland, and England and Wales, and 1 in Switzerland, Germany, Australia and Spain, respectively. In the selected clinical trials, the sample size varied between 236 and 871,058. The basic characteristics of these studies were summarized in Table [1](#T1){ref-type="table"} . In addition, all studies were evaluated as high methodological quality in accordance with the the Newcastle-Ottawa Scale scores.
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Characteristics of the Included Studies.
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Characteristics of the Included Studies.
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3.3. Overall meta-analysis
--------------------------

### 3.3.1. Obesity *vs.* non-obesity

Of the 29 included studies, 20 reported^\[[@R16]--[@R18],[@R20]--[@R25],[@R27]--[@R31],[@R35],[@R38],[@R40]--[@R42]\]^ the correlation between BMI (obesity *vs.* non-obesity) and PJI following TJA. The meta-analysis revealed that the risk of PJI after TJA significantly increased by 1.51 times in the obese group (*OR* = 1.51; 95% CI = 1.30--1.74), with high heterogeneity (*I*^*2*^ = 78.6%, *P* = .000; Fig. [2](#F2){ref-type="fig"}). Thus, subgroup analyses were conducted to investigate the underlying factors that could substantially affect the between-study heterogeneity.

![The meta-analysis results of the correlation between BMI (obesity vs non-obesity) and PJI following TJA. BMI = body mass index, PJI = periprosthetic joint infection, TJA = total joint arthroplasty.](medi-99-e20549-g004){#F2}

### 3.3.2. Morbid obesity *vs.* non-morbid obesity

Data from 14 studies^\[[@R16]--[@R19],[@R22],[@R26],[@R29],[@R35]--[@R38],[@R40],[@R41],[@R44]\]^ on morbid obesity *vs.* non-morbid obesity were available for the meta-analysis. It was found that the risk of PJI after TJA significantly boosted by 3.27 times in the morbid obese group (*OR* = 3.27; 95% CI = 2.46--4.34), with medium heterogeneity (*I*^*2*^ = 69.0%, *P* = .000; Fig. [3](#F3){ref-type="fig"}). Thus, subgroup analyses were conducted to investigate the potential factors that could substantially affect the between-study heterogeneity.

![The meta-analysis of the correlation between BMI (morbid obesity vs. non-morbid obesity) and PJI after TJA. BMI = body mass index, PJI = periprosthetic joint infection, TJA = total joint arthroplasty.](medi-99-e20549-g005){#F3}

### 3.3.3. BM≥ 35 kg/m^2^*vs.* BMI \< 35 kg/m^2^

Data from 5 studies^\[[@R17],[@R33],[@R36],[@R39],[@R44]\]^ on BMI ≥ 35 kg/m^2^ vs BMI \< 35 kg/m^2^ were available for the meta-analysis. The analysis revealed that the risk of PJI after TJA significantly rose by 1.64 times in patients with BMI ≥ 35 kg/m^2^ (*OR* = 1.64; 95% CI = 1.39--1.94), with low heterogeneity (*I*^*2*^ = 13.2%, *P* = .330; Fig. [4](#F4){ref-type="fig"}).

![The meta-analysis of the correlation between BMI (BMI ≥ 35 kg/m^2^ vs. BMI \< 35 kg/m^2^) and PJI after TJA. BMI = body mass index, PJI = periprosthetic joint infection, TJA = total joint arthroplasty.](medi-99-e20549-g006){#F4}

### 3.3.4. BMI ≥ 50 kg/m^2^*vs.* BMI 40--50 kg/m^2^

Data from 2 studies^\[[@R29],[@R34]\]^ on BMI ≥ 50 kg/m^2^*vs.* BMI 40--50 kg/m^2^ were available for the meta-analysis. It was found that the risk of PJI after TJA significantly increased by 1.68 times in patients with BMI ≥ 50 kg/m^2^ (*OR* = 1.68; 95%CI = 1.25--2.24), with nonsignificant heterogeneity (*I*^*2*^ = 0%, *P* = .532; Fig. [5](#F5){ref-type="fig"}).

![Meta-analysis results of the correlation between BMI (BMI≥50 kg/m^2^ vs BMI \<50 kg/m^2^) and PJI after total joint arthroplasty. BMI = body mass index, PJI = periprosthetic joint infection.](medi-99-e20549-g007){#F5}

### 3.3.5. Other BMI comparisons

One study^\[[@R23]\]^ reported a comparison between BMI \< 19 kg/m^2^ and BMI ≥ 19 kg/m^2^ (*OR* = 2.67; 95% CI = 1.07--6.67, *P* = .019). Another^\[[@R18]\]^ reported a comparison between BMI ≥ 25 kg/m^2^ and BMI \< 25 kg/m^2^ (*OR* = 1.09; 95% CI = 1.07--1.12, *P* \< .001). One^\[[@R43]\]^ showed a comparison between BMI ≥ 28 kg/m^2^*vs.* BMI \< 28 kg/m^2^ (*OR* = 2.48; 95% CI = 1.66--3.69, *P* \< .05). And 1 study^\[[@R34]\]^ exhibited a comparison between BMI ≥ 50 kg/m^2^*vs.* BMI \< 25 kg/m^2^ (*OR* = 1.22; 95% CI = 0.58--2.55, *P* \< .05).

3.4. Subgroup analyses
----------------------

### 3.4.1. Subgroup analysis of studies on obesity *vs.* non-obesity

Subgroup analyses of studies on obesity vs non-obesity were conducted, and the results were summarized in Table [2](#T2){ref-type="table"}. When the studies were stratified by BMI, the subgroup analysis showed inconsistencies in the results of comparisons between different BMI intervals. This could attribute to the lack of eligible studies. When the studies were stratified by other factors, the subgroup analysis showed that significant correlations were basically consistent.
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Results of subgroup analyses of studies on obesity *vs.* non-obesity.
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### 3.4.2. Subgroup analysis of studies on morbid obesity *vs.* non-morbid obesity

The subgroup analysis was conducted, with results listed in Table [3](#T3){ref-type="table"}. A statistically significance was observed in the retrospective cohort and prospective cohort studies, but not in prospective case-control studies. When the studies were stratified by the other factors, the subgroup analysis showed that significant correlations remained consistent.

###### 

Subgroup analysis of studies on morbid obesity vs non-morbid obesity.
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3.5. Sensitivity analyses
-------------------------

The sensitivity analysis was performed to assess whether individual studies would affect the overall results. We evaluated the effect of each study on the methodological quality through the sequential exclusion of single studies. The results showed that there was a nonsignificant difference in the stability of the results (Fig. [6](#F6){ref-type="fig"}), which validated the rationality and reliability of our analysis.

![The influence analysis of included studies.](medi-99-e20549-g010){#F6}

3.6. Evaluation of publication bias
-----------------------------------

Egger and Begg analyses of publication bias showed that publication bias did not exist in our meta-analysis (*P* = .854). (Figs. [7](#F7){ref-type="fig"} and [8](#F8){ref-type="fig"}).

![Egger funnel plot.](medi-99-e20549-g011){#F7}

![Begg funnel plot.](medi-99-e20549-g012){#F8}

4. Discussion
=============

In this study, we have conducted a meta-analysis of 29 selected studies to corroborate the correlation between BMI and PJI following TJA. To ensure a reliable conclusion, previous published studies on this topic have been retrieved, reviewed and summarized to achieve those with high compliance and high quality, so as to resolve the controversy over this inconsistent correlation. Overall, our results revealed that the risk of PJI after TJA significantly increased by 1.51 times in the obese group (*OR* = 1.51; 95% CI = 1.30--1.74 for obesity *vs.* non-obesity), the risk of PJI after TJA rose by 3.27 times in the morbid obese group (*OR* = 3.27; 95% CI = 2.46--4.34 for morbid obesity *vs*. non-morbid obesity), the risk boosted by 1.64 times in patients with BMI ≥ 35 kg/m^2^ (*OR* = 1.64; 95% CI = 1.39--1.94 for BMI≥35 kg/m^2^ vs BMI\<35 kg/m^2^), and by 1.68 times in those with BMI≥50 kg/m^2^ (*OR* = 1.68;95%CI = 1.25--2.24 for BMI≥50 kg/m^2^ vs BMI 40--50 kg/m^2^). A significant association remained consistent, as indicated by subgroup analyses. In addition, Egger and Begg analyses merely showed no publication bias. The sensitivity analysis revealed that there was a nonsignificant difference in the stability of the results, further verifying the rationality and reliability of our analysis.

TJA as a successful, cost-effective and selective surgical treatment has been universally used to treat joint pain mainly caused by osteoarthritis. Some patients experience complications and 1 of the most severe complications is PJI^\[[@R45]\]^. The identification of individuals at high risks of PJI can facilitate the development of preventive strategies with optimized detection of PJI. Though the correlation between BMI and PJI after TJA has been rapidly reported, their results still remain divergent and even controversial^\[[@R16]--[@R44]\]^. Our results suggest that the 1.51-fold risk of PJI after TJA in obese patients is consistent with previous studies^\[[@R8]--[@R10]\]^. By analyzing studies on obesity *vs.* non-obesity, we have found differences between various BMI stratification levels. In general, the growing risk of PJI is BMI-dependent. However, some comparisons have shown nonsignificant differences. This may attribute to the insufficient inclusion of eligible studies after BMI stratification. The 3.27-fold risk of PJI after TJA in the morbid obese group is consistent with the meta-analysis reported by Ma et al.^\[[@R9]\]^. However, his study has not adjusted for confounders despite few included studies. With regard to the subgroup analysis of studies on morbid obesity *vs.* non-morbid obesity, the correlations remain consistent when the studies are stratified by different BMI intervals. We have even compared a seldom reported BMI interval at 35 kg/m^2^ in previous studies, and the present analysis reveals a 1.64-fold risk of PJI after TJA in patients with BMI≥35 kg/m^2^. Furthermore, the risk can significantly increase by 1.68 times when the indice rises to over 50 kg/m^2^ (as shown in the subgroup analysis of studies on BMI≥50 kg/m^2^ vs BMI 40--50 kg/m^2^). However, due to the insufficient included studies in this part, more large sample studies are needed for verification.

As the passages have expounded, 2 significant advantages of our study are clear. First, as the previously calculated correlation between BMI and PJI following TJA is uncertain, this meta-analysis assesses such a potential correlation through a thorough systematic study with rigorous analytical methods. Second, only multi-factor adjustment studies are included to exclude the influence from other confounders on the results. Third, the rationality and reliability of our meta-analysis have been prudently and significantly improved in that the overall comprehensive estimation is based on a large sample size. In addition, sufficient sensitivity analyses have been carried out to ensure the reliability of this study.

The current meta-analysis has the following limitations which must be considered before our results can be accepted. First, there are significant heterogeneities across the included studies, and a subgroup analysis can not fully trace each underlying source of heterogeneity. Second, retrospective and prospective studies are included in this meta-analysis. Thus, the heterogeneous design may limit their comparability and eventually the interpretability of the current meta-analysis. Third, this study only includes references in English. Therefore, we may have lost data from those in other languages.

5. Conclusion
=============

In summary, our meta-analysis suggests that PJI after TJA is correlated with BMI, and that means obese patients have higher risks of developing PJI than non-obese individuals. Similarly, morbid obese patients show higher risks of such infections than non-morbid obese patients. This conclusion needs to be verified by more prospective studies. A significant association remains consistent, as indicated by subgroup analyses and sensitivity analyses.
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